{{Rsnum
|rsid=3916968
|Gene=DAOA
|Chromosome=13
|position=105475180
|Orientation=minus
|GMAF=0.2856
|Gene_s=DAOA
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.8 | 36.3 | 54.9
| HCB | 2.9 | 29.9 | 67.2
| JPT | 4.4 | 33.6 | 61.9
| YRI | 8.8 | 42.2 | 49.0
| ASW | 7.0 | 49.1 | 43.9
| CHB | 2.9 | 29.9 | 67.2
| CHD | 6.4 | 33.9 | 59.6
| GIH | 7.9 | 36.6 | 55.4
| LWK | 17.3 | 34.5 | 48.2
| MEX | 6.9 | 27.6 | 65.5
| MKK | 32.1 | 47.4 | 20.5
| TSI | 12.7 | 41.2 | 46.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=22122005
|Title=DAOA variants and schizophrenia: influence on diagnosis and treatment outcomes
}}

{{PMID Auto
|PMID=16842973
|Title=No association of G72 and D-amino acid oxidase genes with schizophrenia.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}